Antineutrophil cytoplasmic antibodies in primary Sjogren's syndrome: Prevalence and clinical significance

British Journal of Rheumatology

Volumn 37, Issue 12, 1998, Pages 1287-1291

  Font, J ^a,d   Ramos Casals, M ^a   Cervera, R ^a   Bosch, X ^a   Mirapeix, E ^b   Garcia Carrasco M ^c   Morla R M ^a   Ingelmo, M ^a  

^a Systemic Autoimmune Diseases Unit   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

ANCA; Cutaneous vasculitis; Primary Sjogren's syndrome

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PARAFORMALDEHYDE;

ADULT; AGED; ANTIBODY TITER; ARTHRALGIA; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HASHIMOTO DISEASE; HUMAN; IMMUNOFLUORESCENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SJOEGREN SYNDROME; VASCULITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SJOGREN'S SYNDROME; SKIN; VASCULITIS;

EID: 0032412189     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Talal N. Clinical and pathogenetic aspects of Sjögren's syndrome. Semin Clin Immunol 1993;6:11-20.
2. Anaya JM, Gutierrez M, Espinosa LR. Síndrome de Sjögren primario. Manifestaciones clínicas extraglandulares. Rev Esp Reumatol 1994;21:337-42.
3. Ramos M, Cervera R, García-Carrasco M et al. Síndrome de Sjögren primario: características clínicas e inmunológicas en una serie de 80 pacientes. Med Clin (Barc) 1997;108:652-7.
4. Davis M, Moran J, Niall J et al. Segmental necrotizing glomerulonephritis with antineutrophil antibody. Br Med J 1982;2:606.
5. Jayne DRW, Rasmussen N. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc 1997;72:737-47.
6. Jennette JC, Falk RJ. Diagnostic classification of antineutrophil cytoplasmic autoantibody-associated vasculitides. Am J Kidney Dis 1991;18:184-7.
7. Gross WL. Antineutrophil cytoplasmic autoantibody testing in vasculitis. Rheum Dis Clin North Am 1995;21:987-1011.
8. Snook JA, Chapman RW, Feming K, Jewel DP. Antineutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1989;76:30-3.
9. Pudifin DJ, Duursma J, Gathiram V, Jackson TF. Invasive amoebiasis is associated with the development of antineutrophil cytoplasmic antibody. Clin Exp Immunol 1994;97:48-51.
10. Klassen RJ, Goldschmeding R, Dolman KM et al. Antineutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. [Letter] Lancet 1990;335:1227-8.
11. Cohen Tervaert JW, Mulder AHL, Horst G, Haagsma EB, Kleibeuker JH, Kallenberg CGM. Antineutrophil cytoplasmic autoantibodies in autoimmune liver diseases. [Letter] Gastroenterology 1992;102:1090.
12. Bosch X, Llena J, Collado A et al. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)-nuclear antibodies in rheumatoid arthritis. J Rheumatol 1995;22:2038-45.
13. Bosch X, Font J, Mirapeix E, Cid MC, Revert L, Ingelmo M. Antineutrophil cytoplasmic antibodies in giant cell arteritis. [Letter] J Rheumatol 1991;18:787-8.
14. Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Cohen Tervaert JW et al. Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Br J Rheumatol 1996;35:625-31.
15. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM et al. Preliminary criteria for the classification of Sjögren's syndrome. Arthritis Rheum 1993;36:340-7.
16. Alexander EL, Provost TT. Cutaneous manifestations of primary Sjögren's syndrome: a reflection of vasculitis and association with anti-Ro(SS-A) antibodies. J Invest Dermatol 1983;80:386-91.
17. Molina R, Provost TT, Alexander EL. Two types of inflammatory vascular disease in Sjögren's syndrome. Differential association with seroreactivity to rheumatoid factor and antibodies to Ro(SS-A) and with hypocomplementemia. Arthritis Rheum 1985;28:1251-8.
18. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989;97(suppl. 6):12-3.
19. Bosch X, Mirapeix E, Font J et al. Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis. Am J Kidney Dis 1992;20:231-9.
20. Bosch X, López-Soto A, Mirapeix E, Font J, Ingelmo M, Urbano-Márquez A. Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage. Arch Pathol Lab Med 1994;118:517-22.
21. Mulder AHL, Horst G, van Leeuwen MA, Limburg PC, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlations. Arthritis Rheum 1993;36:1054-60.
22. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criteria in 362 suspected cases. Arthritis Rheum 1984;27:141-56.
23. Böttinger EP, Niles JL, Collins B, McCluskey RT, Amin Arnaout M. Antineutrophil cytoplasmic autoantibody-associated vasculitis presenting as Sjögren's syndrome. Arthritis Rheum 1992;35:1373-6.
24. Kallenberg CGM, Mulder AHL, Cohen Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992;93:675-82.
25. Coll J, Rives A, Griñó MC, Setoain J, Vivancos J, Balcells A. Prevalence of Sjögren's syndrome in autoimmune diseases. Ann Rheum Dis 1987;46:286-9.
26. Alexander EL, Arnett FC, Provost TT, Stevens MB. Vasculitis in Sjögren's syndrome: association of anti-Ro (SSA) antibodies with vasculitis, hematologic abnormalities and serologic hyper-reactivity. Ann Intern Med 1983;98:155-9.
27. De Bandt M, Ollivier V, Meyer O et al. Induction of interleukin-1 and subsequent tissue factor expression by anti-proteinase 3 antibodies in human umbilical vein endothelial cells. Arthritis Rheum 1997;40:2030-8.